About Medicine OnLine Medicine OnLine Home PageCancer LibrariesDoseCalc OnlineOncology News
Cancer ForumsMedline SearchCancer LinksGlossary

Navelbine

Navelbine Bibliography


Other Cancers

George MJ, Heron JF, Kerbrat P, Chauvergne J, Goupil A, Lebrun D, et al. Navelbine in advanced ovarian epithelial cancer: A Study of the French Oncology Centers. Semin Oncol 1989;16(2; Suppl 4):30-2 (#1744090/2).

Pinel MC, Pinon G, Goudier MJ, Coiffier B, Filippi MH, Blaise JP, et al. Navelbine (N) and hexamethyl-melamine (H) (N-H) as second or further line chemotherapy regimen in advanced ovarian carcinoma: An ARTAC phase II study. Proc Am Soc Clin Oncol 1990;9:166, Abs No. 644 (#2102157/2).

Fields S, Burris H, Wilding G, Eckardt J, O'Rourke T, Rinaldi D, et al. Evaluating the role of Navelbine in hormone-refractory prostate cancer (HRPC): a clinical benefit model. Proc Am Soc Clin Oncol 1994;13:235, Abs No. 727.

Canobbio L, Boccardo F, Guarneri D, Calabria C, Decensi A, Curotto A, et al. Phase II study of Navelbine in advanced renal cell carcinoma. Eur J Cancer 1991;27(6):804-5 (#2995830/2).

Wilding G, Kirkwood J, Clamon G, Koletsky A, Goodman G, O'Rourke M, et al. Phase II trial of Navelbine in metastatic renal cancer. Proc Am Soc Clin Oncol 1993;12:253, Abs No. 798 9 (#5898855/2).

Benchekroun S, Chouffai Z, Harif M. Clinical study of NavelbineÒ activity in Hodgkin's disease. Phase II study. In: Solal-Celigny P, editor. Navelbine (vinorelbine): update and new trends. Paris: John Libbey Eurotex, 1991;261-4.

Bruno S, Savignano R, Corrado C, Aris Cancela ME, Milone G, Lastiri FJ, et al. Vinorelbine (NVB): a new vinca alkaloid active in refractory/relapsed lymphomas. A phase II study. Proc Am Soc Clin Oncol 1994;13:383, Abs No. 1300.

Ferme C, Oberlin O, Bounbdallah, Morel P, Schmitt C, Auzanneau G, et al. Methyl-GAG, ifosfamide, Navelbine, etoposide (MINE) as salvage therapy for refractory or relapsed Hodgkin's disease (HD). Proc Am Soc Clin Oncol 1991;10:278, Abs No. 970 (#4220853/2).

Furuse K, Kawahara M, Fukuoka M, Kimura I, Fujii A, Oota M. Early phase II study of vinorelbine (VNR) in small cell lung cancer. J Internat Assoc Study Lung Cancer 1994;11(Suppl 1):107, Abs No. 409.

Jessem J, Karnicka-Mlodkowska H, van Pottelsberghe Ch, van Glabbeke M, Noseda MA, Ardizzoni A, et al. Phase II study of vinorelbine (Navelbine) in previously treated small cell lung cancer patients. Eur J Cancer 1993;29A(12):1720-2 (#5449871/2).

Bokemeyer C, Droz JP, Hanauske A, Schroder M, Queisser W, Schmoll HJ et al. Treatment of relapsed nonseminomatous germ-cell tumors with vinorelbine-a trial of the phase I-II study group of the Association-for Medical-Oncology of the German-Cancer-Society. Onkologie 1993;16(1):29-31 (#4820757/2).

Le Cesne A, Droz JP, Kattan J, Mahjoubi M, Marino JP, Ghosn M, et al. Phase II trial of a combination of ifosfamide (I), Navelbine (N) and epirubicin (E) as salvage chemotherapy (CT) in refractory germ cell tumors (RGCT). Proc Am Soc Clin Oncol 1991;10:174, Abs No. 559 (#4220856/2)

Gebbia V, Testa A, Valenza R, Ferrero B, Giuffre S, Carreca I, et al. Vinorelbine plus cisplatin and 5-fluorouracil in recurrent and/or metastatic squamous cell head and neck carcinoma. Proc Am Soc Clin Oncol 1993;12:283, Abs No. 917 (#5898852/2).

Gebbia V, Testa A, Valenza R, Zerillo G, Restivo S, Ingria F, et al. A pilot study vinorelbine on a weekly schedule in recurrent and/or metastatic squamous cell carcinoma of the head and neck. Eur J Cancer 1993;29A(9):1358-9 (#4985817/2).

Romanini A, Surbone A, Ricci S, Conte PF. Phase II study of continuous infusion of vinorelbine (CIV) in patients with locally pretreated advanced head and neck cancer. Proc Am Assoc Cancer Research 1993;34:205, Abs No. 1222 (#5590167/2).

Testolin A, Recher G, Pozza F, Panizzoni G, Gasparini G. Vinorelbine (VNB) in pre-treated advanced head & neck squamous cell carcinoma (AH & NSCC): a phase II study. Proc Am Soc Clin Oncol 1994;13:289, Abs No. 938.

Conroy T, Etienne PL, Adenis A, Francois E, Wagener DJTh, Paillot B, et al. Vinorelbine (Navelbine): a promising drug in metastatic epidermoid carcinoma (MEEC). Proc Am Soc Clin Oncol 1993;12:191, Abs No. 553.

Peacock NW, Burris HA, Smith L, Rodriguez GI, Eckardt JR, Fields S, et al. A phase I trial of Navelbine in combination with mitoxantrone in patients with refractory solid tumors. Proc Am Soc Clin Oncol 1994;13:102, Abs No. 209.

Fournier C, Hecquet B, Bouffard P, Vert M, Caty A, Vilain MO, et al. Experimental studies and preliminary clinical trial of vinorelbine-loaded polymeric bioresorbable implants for the local treatment of solid tumors. Cancer Res 1991;51(19):5384-91 (#2690871/2).

Agostara B, Gebbia V, Testa A, Cusimano MP, Gebbia N, Callari AM. Mitomycin-C and vinorelbine as 2nd line chemotherapy for metastatic breast-carcinoma. Tumori 1994;80(1):33-6 (#6510426/2).

Blajman C, Balbiani L, Block J, Bianchi R, Temperley G, Chacon R, et al. Navelbine (N) plus Adriamycin (A) vs FAC in advanced breast cancer (ABC). Proc Am Soc Clin Oncol 1993;12:92, Abs No. 170 (#5898864/2).

Botto HG, Galmarini F, Galvez C. Mitoxantrone (M), ifosfamide (I), vinorelbine (V), (MIV) and GM-CSF in refractory metastatic breast cancer (RMBC). Proc Am Soc Clin Oncol 1994;13:85, Abs No. 143.

Bruno S, Lira-Puerto V, Texeira L, Mickiewicz E, Fernandez O, Martinez L, et al. Phase II trial with vinorelbine, (Navelbine, NVB) in the treatment of advanced breast cancer (ABC). Ann Oncol 1992;3(Suppl 1):126, Abs No. 268A (#6151049/2).

Canobbio L, Boccardo F, Pastorino G, Brema F, Martini C, Resasco M, et al. Phase-II study of Navelbine in advanced breast cancer. Semin Oncol 1989;16(2; Suppl 4):33-6 (#4661842/2).

Chadjaa M, Izzo J, May-Levin F, Riggi M, Cvitkovic E, Armand JP. Preliminary data on 4'epidriamycine (EPI)-vinorelbine (VNB): A new active combination in advanced breast cancer (ABC). Proc Am Soc Clin Oncol 1993;12:88, Abs No. 152 (#5898885/2).

Cole JT, Gralla RJ, Kardinal CG. Navelbine and mitomycin C: Combination therapy in advanced breast cancer. Breast Cancer Research Treat 17th Ann San Antonio Breast Cancer Symp 1994;32:33, Abs No. 18.

Coppola F, Balbiani L, Blajman C, Vilanova P, Bonicatto S, Rufino C, et al. Vinorelbine (VNB) containing regimens in three different schedules for the treatment of advanced breast cancer (ABC). Proc Am Soc Clin Oncol 1994;13:85, Abs No. 144.

Degardin M, Bonneterre J, Hecquet B, Pion JM, Adenis A, Horner D, et al. Vinorelbine (Navelbine) as a salvage treatment for advanced breast cancer. Ann Oncol 1994;5(5):423-6 (#6675115/2).

Dieras V, Pierga JY, Extra JM, Giacchetti S, Bellissant E, Espie M, et al. Phase II study of Navelbine (NVB) and Fluorouracil (FU) in metastatic breast cancer (MBC) patients using a group sequential design (GSD). Ann Oncol 1992; 3(Suppl 1):Abs No. 267 (#3134583/2).

Ferrero JM, Wendling JL, Hoch M, Frenay M, Francois M, Namer M. Mitoxantrone (MTZ)-vinorelbine (VNR) as a first-line chemotherapy (CT) in metastatic breast cancer (MBC): A pilot study. Proc Am Soc Clin Oncol 1993;12:108, Abs No. 234 (#5630606/2).

Fumoleau P, Delgado FM, Delozier T, Monnier A, Delgado G, Kerbrat P, et al. Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy. J Clin Oncol 1993;11(7):1245-52 (#5106620/2).

Gasparini G, Caffo O, Barni S, Frontini L, Testolin A, Guglielmi RB, et al. Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: A phase II study. J Clin Oncol 1994;12(10):2094-2101.

Hochster H, Vogel C, Blumenreich M, Davis H, Ozer H, Panella T, et al. A multicenter phase II study of Navelbine (NVB) and doxorubicin (DOX) as first line chemotherapy of metastatic breast cancer. Proc Am Soc Clin Oncol 1994;13:100, Abs No. 203.

Jones S, Winer E, Vogel C, Laufman L, Barlogie B, O'Rourke M, et al. A multicenter randomized trial of IV Navelbine vs. IV Alkeran in patients with anthracycline-refractory advanced breast cancer (ABC). Proc Am Soc Clin Oncol 1994;13:103, Abs No. 216.

Kayitalire L, Spielmann M, Brain E, Sari C, Le Cesne A, Toussaint C, et al. Salvage chemotherapy (CT) with combination of mitoxantrone (MTZ) and vinorelbine (VRB) in resistant to anthracyclines advanced breast cancer (ABC). Proc Am Soc Clin Oncol 1993;12:90, Abs No. 161 (#5898867/2).

Lluch A, Garcia Conde J, Casado A, Martin M, Diaz Rubio E, Oliveira C, et al. Phase II trial with Navelbine (NVB) in advanced breast cancer (ABC) previously untreated. Proc Am Soc Clin Oncol 1992;11:29, Abs No. 115 (#4077633/2).

Marty M, Leandri S, Extra JM, Espie M, Besenval M. A phase II study of vinorelbine in patients with advanced breast cancer. Proc Am Assoc Cancer Res 1989;30:256, Abs No. 1017 (#1559579/2).

Marty M, Extra MJ, Dieras V, Giacchetti S, Ohana S, Espie M. A review of the antitumour activity of vinorelbine in breast cancer. Drugs 1992; 44(Suppl 4):29-35 (#4252472/2).

Meriggi F, Zaniboni A, Arcangeli G, Simoncini E, Marpicati P, Montini E. VELF: an active outpatient regimen for aggressive metastatic breast cancer (MBC). Preliminary results. Proc Am Soc Clin Oncol 1994;13:91, Abs No. 168.

Mustacchi G, Milani S, Sandri P, Piuca E, Muggia M, Carbonara T, et al. Cisplatin-vinorelbine: A new active combination in metastatic breast cancer. Breast Cancer Research Treat 17th Ann San Antonio Breast Cancer Symp 1994;32:36, Abs No. 30.

Van Praagh I, Martineau N, Cure H, Lipinski F, Ravoux M-A, Fleury J, et al. Efficacy of a chemotherapy regimen combining vinorelbine, epirubicine and methotrexate (VEM) in locally advanced and metastatic breast cancer. Proc Am Soc Clin Oncol 1993;12:95, Abs No. 180 (#5898861/2).

Romero A, Rabinovich MG, Vallejo CT, Perez JE, Rodriguez R, Cuevas MA, et al. Vinorelbine as first-line chemotherapy for metastatic breast carcinoma. J Clin Oncol 1994;12(2):336-41 (#6037310/2).

Scheithauer W, Kornek G, Haider K, Kwasny W, Schenk T, Pirker R, et al. Effective second line chemotherapy of advanced breast cancer with Navelbine and Mitomycin C. Breast Cancer Research and Treatment 1993;26: 49-53 (#5493096/2).

Smalley R, Craig J, Jones S, Ervin T, Hohneker J. Navelbine and Adriamycin (NA) in combination for advanced breast cancer: phase I-II evaluation of a new schedule. Proc Am Soc Clin Oncol 1994;13:89, Abs No. 157.

Spielmann M, Dorval T, Turpin F, Antoine E, Jouve M, Maylevin F, et al. Phase II trial of vinorelbine/doxorubicin as first-line therapy of advanced breast cancer. J Clin Oncol 1994;12(9):1764-70.

Spielmann M, Llombart-Cussac A, Roset A, Antyoine E. Le Cesna A, Janin N, et al. Efficacy of a chemotherapy regimen combining vinorelbine and mitoxantrone in advanced breast cancer patients resistant to anthracycline regimen. Breast Cancer Research Treat 17th Ann San Antonio Breast Cancer Symp 1994;32:33, Abs No. 20.

Tresca P, Fumoleau P, Roche H, Pinon G, Serin D, Marie FN, et al. Vinorelbine, a new active drug in breast carcinoma results of an ARTAC Phase II trial. Breast Cancer Res Treat 1990;16(2):161, Abs No. 66 (#4512011/2).

Toussaint C, Izzo J, Spielmann M, Merle S, May-Levin F, Armand JP, et al. Phase I/II trial of continuous infusion vinorelbine for advanced breast cancer. J Clin Oncol 1994;12(10):2102-12.

Weber B, Vogel C, Jones S, Harvey H, Hutchins U, Purvis J, et al. A U.S. multicenter phase II trial of Navelbine in advanced breast cancer. Proc Am Soc Clin Oncol 1993;12:61, Abs No. 46 (#5898888/2).


Top | Lung Library Index | Navelbine Index | Navelbine Bibliography | Next ]

About Medicine OnLine Medicine OnLine Home PageCancer LibrariesDoseCalc OnlineOncology News
Cancer ForumsMedline SearchCancer LinksGlossary